论文部分内容阅读
我们对33例肝硬化患者进行了血清透明质酸(HA)、Ⅲ型前胶原(PCⅢ)、Ⅵ型胶原(CⅥ)、层粘连蛋白(LN)、脯氨酸肽酶(PLD)五项指标进行了测定,并就临床意义作初步讨论,现将结果报道如下。 对象和方法 一、对象: (一)正常人:35人(男21,女14)。均为我院门诊体检合格的健康人,心、肝、肺、肾等重要脏器无疾患,肝、肾功能试验正常,年龄21～29岁,平均25.6岁。 (二)病人组:33人(男25,女8),均为临床上明确诊断的肝硬化患者,其中有肝硬化腹水组8人、无腹水组25人。全部病例经B超、CT和实验室检查确诊,部分病例经核磁共振和病理检查确诊,年龄26～51岁,平均41.8岁。
In our study of 33 patients with liver cirrhosis, five indicators of serum HA, PCⅢ, CVI, LN and PLD Carried out the determination, and to make a preliminary discussion on the clinical significance, the results are reported below. Objects and methods First, the object: (a) normal: 35 (male 21, female 14). All of them were healthy people who passed out-patient examination in our hospital. Heart, liver, lung, kidney and other important organs were free of disease. Their liver and kidney function tests were normal. They were 21 to 29 years old with an average of 25.6 years old. (B) the patient group: 33 (male 25, female 8), are clinically diagnosed patients with cirrhosis, including cirrhosis ascites group of 8 people, 25 patients without ascites group. All cases were diagnosed by B ultrasound, CT and laboratory tests. Some cases were diagnosed by MRI and pathology, aged from 26 to 51 years with an average of 41.8 years old.